CH556351A - Verfahren zur herstellung neuer trisubstituierter oxazole. - Google Patents

Verfahren zur herstellung neuer trisubstituierter oxazole.

Info

Publication number
CH556351A
CH556351A CH1717071A CH1717071A CH556351A CH 556351 A CH556351 A CH 556351A CH 1717071 A CH1717071 A CH 1717071A CH 1717071 A CH1717071 A CH 1717071A CH 556351 A CH556351 A CH 556351A
Authority
CH
Switzerland
Prior art keywords
preparing new
oxazoles
new trisubstituted
trisubstituted oxazoles
preparing
Prior art date
Application number
CH1717071A
Other languages
German (de)
English (en)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of CH556351A publication Critical patent/CH556351A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02Holding devices, e.g. on the body
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH1717071A 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole. CH556351A (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14
CH1606467A CH528531A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer heterocyclischer Verbindungen aromatischen Charakters

Publications (1)

Publication Number Publication Date
CH556351A true CH556351A (de) 1974-11-29

Family

ID=27516268

Family Applications (9)

Application Number Title Priority Date Filing Date
CH1717071A CH556351A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole.
CH1717271A CH536311A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxagole
CH1606467A CH528531A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer heterocyclischer Verbindungen aromatischen Charakters
CH1717171A CH545310A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1717371A CH560205A5 (enExample) 1966-11-18 1967-11-16
CH1648872A CH554884A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole bzw. thiazole.
CH1716871A CH545308A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1716971A CH545309A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1485573A CH560203A5 (enExample) 1966-11-18 1967-11-16

Family Applications After (8)

Application Number Title Priority Date Filing Date
CH1717271A CH536311A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxagole
CH1606467A CH528531A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer heterocyclischer Verbindungen aromatischen Charakters
CH1717171A CH545310A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1717371A CH560205A5 (enExample) 1966-11-18 1967-11-16
CH1648872A CH554884A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole bzw. thiazole.
CH1716871A CH545308A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1716971A CH545309A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1485573A CH560203A5 (enExample) 1966-11-18 1967-11-16

Country Status (12)

Country Link
JP (1) JPS4938267B1 (enExample)
BE (1) BE706625A (enExample)
CH (9) CH556351A (enExample)
DE (2) DE1670005C2 (enExample)
ES (1) ES347319A1 (enExample)
FI (1) FI50416C (enExample)
FR (2) FR8018M (enExample)
IL (1) IL28803A (enExample)
LU (1) LU54891A1 (enExample)
NL (1) NL157012B (enExample)
PL (1) PL72562B1 (enExample)
SE (2) SE369307B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2618547A1 (de) * 1975-05-02 1976-11-18 Lilly Industries Ltd Oxazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
JPS5113375U (enExample) * 1974-07-18 1976-01-30
JPS5182675A (enExample) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
DK1130017T3 (da) * 1990-11-30 2005-10-10 Otsuka Pharma Co Ltd Azolderivater og deres anvendelse som superoxidradikalinhibitorer
AU3201095A (en) * 1994-07-27 1996-02-22 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (enExample) * 1965-10-07

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2618547A1 (de) * 1975-05-02 1976-11-18 Lilly Industries Ltd Oxazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
CH545309A (de) 1973-12-15
DE1670005A1 (de) 1970-08-06
LU54891A1 (enExample) 1968-02-08
SE369307B (enExample) 1974-08-19
CH554884A (de) 1974-10-15
FI50416B (enExample) 1975-12-01
PL72562B1 (en) 1974-08-30
BE706625A (enExample) 1968-05-16
SE422209B (sv) 1982-02-22
CH545308A (de) 1973-12-15
CH536311A (de) 1973-04-30
ES347319A1 (es) 1969-05-16
IL28803A (en) 1974-05-16
CH528531A (de) 1972-09-30
DE1670005C2 (de) 1982-06-09
FI50416C (fi) 1976-03-10
DE1795822C2 (de) 1982-07-15
FR1584222A (enExample) 1969-12-19
CH560203A5 (enExample) 1975-03-27
JPS4938267B1 (enExample) 1974-10-16
NL157012B (nl) 1978-06-15
CH545310A (de) 1973-12-15
CH560205A5 (enExample) 1975-03-27
FR8018M (enExample) 1970-08-03
NL6715532A (enExample) 1968-05-20

Similar Documents

Publication Publication Date Title
AT260948B (de) Verfahren zur Herstellung neuer, substituierter Hydroxyhydrocarbyloxyalkylsiloxane
AT285628B (de) Verfahren zur herstellung neuer organosiliziumverbindungen
CH556351A (de) Verfahren zur herstellung neuer trisubstituierter oxazole.
CH555828A (de) Verfahren zur herstellung neuer substituierter aminopyridine.
CH511856A (de) Verfahren zur Herstellung neuer trisubstituierter 2-Aryl-aminoimidazoline
AT265312B (de) Verfahren zur Herstellung neuer, cyclischer Tetraphosphonatverbindungen
CH546214A (de) Verfahren zur herstellung neuer substituierter hydroxyphenylalkylamine.
CH441332A (de) Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide
AT269137B (de) Verfahren zur Herstellung neuer Oxazolidinderivate
AT277480B (de) Verfahren zur Herstellung neuer D Homosteroide
CH482724A (de) Verfahren zur Herstellung neuer Aminooxysilane
CH558373A (de) Verfahren zur herstellung neuer azacycloaliphatischer verbindungen.
CH443310A (de) Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone
CH520156A (de) Verfahren zur Herstellung neuer Perhydro-5-phenylcyclo-alkapolyen-1,4-oxazepine
CH517103A (de) Verfahren zur Herstellung neuer 5-Aryl-, bzw. Heteroaryl-Benzotetrahydrodiazepin-24-dione
CH489454A (de) Verfahren zur Herstellung neuer a-Halogenxcyclobutanone
CH464204A (de) Verfahren zur Herstellung neuer Isoxazole
CH471136A (de) Verfahren zur Herstellung neuer 1,3-Dihydro-5-aryl-2H-1,4-benzodiazepin-2-on-4-oxyde
AT278834B (de) Verfahren zur Herstellung neuer Benzotriazinone
CH476689A (de) Verfahren zur Herstellung neuer polymerisierbarer N-Aryl-methylcarbonsäureamide
CH470346A (de) Verfahren zur Herstellung neuer substituierter Aryloxy-2-hydroxy-3-aminopropane
AT280493B (de) Verfahren zur Herstellung neuer Gona-4,9,11-triene
AT274791B (de) Verfahren zur Herstellung neuer N-acylierter Halogenbenzol-2,4-disulfonamide
CH472437A (de) Verfahren zur Herstellung neuer Antibiotika
CH486463A (de) Verfahren zur Herstellung neuer azabicycloaliphatischer Verbindungen

Legal Events

Date Code Title Description
PL Patent ceased